Patents by Inventor Vanessa R. Voskinarian-Berse

Vanessa R. Voskinarian-Berse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of producing erythrocytes
    Patent number: 9200253
    Abstract: Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: December 1, 2015
    Assignee: Anthrogenesis Corporation
    Inventors: Mohammad A. Heidaran, Xiaokui Zhang, Lin Kang, Andrew Zeitlin, Vanessa R. Voskinarian-Berse, Stewart Ernest Abbott
  • TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS
    Publication number: 20090252710
    Abstract: Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
    Type: Application
    Filed: September 29, 2008
    Publication date: October 8, 2009
    Applicant: Celgene Cellular Therapeutics
    Inventors: Xiaokui Zhang, Vanessa R. Voskinarian-Berse, Lin Kang, Neerav Dilip Padliya
  • ANGIOGENIC CELLS FROM HUMAN PLACENTAL PERFUSATE
    Publication number: 20090104164
    Abstract: Provided herein are the production of vasculogenic or angiogenic cells from placental perfusate. Also provided are methods of treating an individual having a cardiac or vascular insufficiency, disease, disorder or condition comprising administering to said individual placental perfusate, placental perfusate cells, or combinations of placental perfusate or perfusate cells with placental or non-placental hematopoietic stem cells or adherent placental stem cells.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 23, 2009
    Applicant: Celgene Cellular Therapeutics
    Inventors: Xiaokui Zhang, Mohammad A. Heidaran, Vanessa R. Voskinarian-Berse, Lin Kang, Henry Rendon Barragan